2006 Clinical Trials Consumption Medicine 
Greencamp
AUGUST 16, 2018
The first study I will reference is from 2006, conducted on mice. As for the side effects of cannabis consumption, patients noted vertigo, soreness of throat, dry mouth , red eyes and difficulties with coordination. An agonist is a chemical which binds to a cell receptor, causing it to perform a biological reaction.
Cannabis Law Report
NOVEMBER 24, 2021
Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
OCTOBER 7, 2019
Also of interest, The American Journal of Medicine adds: We found significant associations between marijuana use and smaller waist circumferences. Stimulating CB1 receptors with THC results in up-regulation across the board (meaning most patients will experience an increase in appetite and calorie consumption).
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.
Expert insights. Personalized for you.
94 
Let's personalize your content